NCT07277491 is a clinical trial in Spondyloarthritis (SpA), sponsored by Cairo University.

Who is sponsoring NCT07277491?

NCT07277491 is sponsored by Cairo University.

What condition does NCT07277491 study?

NCT07277491 studies Spondyloarthritis (SpA), Psoriatic Arthritis (PsA), Systemic Lupus Erythematous (SLE), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA.

Is NCT07277491 still recruiting?

NCT07277491 is currently recruiting now. Last updated 9 March 2026.

Last reviewed 2026-03-09 · How we verify

NCT07277491

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity

Recruiting now Last updated 9 March 2026

What this trial tests

trial in Spondyloarthritis (SpA) in 460 participants. Currently enrolling.

Timeline

1 January 2023

Primary endpoint
28 February 2026

28 February 2026

Quick facts

Lead sponsor	Cairo University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	460
Start date	1 January 2023
Primary completion	28 February 2026
Estimated completion	28 February 2026
Sites	1 location across Egypt

Conditions studied

Spondyloarthritis (SpA) — all drugs for Spondyloarthritis (SpA) →
Psoriatic Arthritis (PsA) — all drugs for Psoriatic Arthritis (PsA) →
Systemic Lupus Erythematous (SLE) — all drugs for Systemic Lupus Erythematous (SLE) →
Systemic Sclerosis (SSc) — all drugs for Systemic Sclerosis (SSc) →

Sponsor

Cairo University

Who can join

18 and older, any sex, with Spondyloarthritis (SpA) or Psoriatic Arthritis (PsA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present work is to assess the nutritional status among different rheumatic diseases patients and to study its association with the corresponding diseases activity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spondyloarthritis (SpA)

Currently open trials in the same condition.

NCT06707194 — Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis · Phase 4 · recruiting
NCT06988813 — Bidirectional Cohort Study of Nanfang Spondyloarthritis · recruiting
NCT05200715 — AutoInflammatory Disease Alliance Registry (AIDA) · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07277491 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 9 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07277491.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing